Abiopharma

New Form 8-K - Qualigen Therapeutics, Inc. Filed: 2025-09-08 AccNo: 0001641172-25-026864 Size: 202 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing